Literature DB >> 12270859

Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease.

Olaimatu S Mahdi1, Benjamin D Horne, Kelly Mullen, Joseph B Muhlestein, Gerald I Byrne.   

Abstract

BACKGROUND: Evidence for an association between Chlamydia pneumoniae infection and coronary artery disease (CAD) has been reported by numerous studies, cross-reactive heat shock protein (Hsp) antibody responses have been causally linked to CAD, and the severity of chlamydial disease pathogenesis correlates with Hsp serology. Our aim was to determine if chlamydial Hsp (cHsp) antibody responses are predictive of CAD. METHODS AND
RESULTS: Patients were recruited in a case-control study: 250 cases had angiographically significant CAD (stenosis > or =70%), and 250 controls had normal coronary arteries (stenosis <10%). Serum immunoglobulin G reactivity to Hsp10 and Hsp60 antigens (chlamydial, Escherichia coli, and human), and C pneumoniae whole organisms were measured by ELISA. Univariate analysis confirmed that classical CAD risk factors were predictors of CAD. Univariate analysis showed that cHsp60 (P= 0.001, OR 3.9), cHsp10 (P=0.045, OR 3.8), E coli Hsp60 (P=0.04, OR 1.5) and C pneumoniae (P=0.03, OR 1.8) ELISA optical density (OD) values were significantly different between cases and controls. Multivariate analysis found that only upper-quintile cHsp60 seroreactivity remained a significant predictor of CAD after controlling for classical CAD risk factors and seroreactivity to the other antigens (cHsp60 OD, P=0.005, OR 3.9 per OD unit; cHsp60 quintile, 5 versus 1 to 4; P=0.01, OR 2.1).
CONCLUSIONS: The presence of elevated anti-cHsp60 immunoglobulin G antibodies, but not anti-human or anti-E coli homologs, was independently associated with CAD. This finding argues against previous suggestions that cross-reactive or autoimmune Hsp60 responses may contribute to disease progression. High anti-cHsp60 antibody response appears to identify the subset of patients with chlamydial infection and significant CAD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270859     DOI: 10.1161/01.cir.0000031567.10814.d8

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Heat-inactivated C. pneumoniae organisms are not atherogenic.

Authors:  Jyotika Sharma; Yuhong Niu; Jianbo Ge; Grant N Pierce; Guangming Zhong
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

2.  Heat shock proteins in cardiovascular disease and the prognostic value of heat shock protein related measurements.

Authors:  A G Pockley; J Frostegård
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

3.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

4.  Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis.

Authors:  V P van Halm; M C Slot; M T Nurmohamed; J W Cohen Tervaert; B A C Dijkmans; A E Voskuyl
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

5.  Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain.

Authors:  D H Birnie; L E Vickers; W S Hillis; J Norrie; S M Cobbe
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

6.  New perspectives of infections in cardiovascular disease.

Authors:  Ignatius W Fong
Journal:  Curr Cardiol Rev       Date:  2009-05

7.  Antibiotics for secondary prevention of coronary heart disease.

Authors:  Naqash J Sethi; Sanam Safi; Steven Kwasi Korang; Asbjørn Hróbjartsson; Maria Skoog; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23

8.  Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma.

Authors:  David L Hahn; Mary Beth Plane; Olaimatu S Mahdi; Gerald I Byrne
Journal:  PLoS Clin Trials       Date:  2006-06-30

9.  Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study.

Authors:  Marjan C Slot; Ruud Theunissen; Pieter van Paassen; Jan G M C Damoiseaux; Jan Willem Cohen Tervaert
Journal:  J Autoimmune Dis       Date:  2006-05-05

10.  Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory.

Authors:  Hamidreza Honarmand
Journal:  Interdiscip Perspect Infect Dis       Date:  2013-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.